BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21680761)

  • 1. Reversible posterior leukoencephalopathy syndrome in a patient treated with ustekinumab: case report and review of the literature.
    Gratton D; Szapary P; Goyal K; Fakharzadeh S; Germain V; Saltiel P
    Arch Dermatol; 2011 Oct; 147(10):1197-202. PubMed ID: 21680761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible Posterior Leukoencephalopathy Syndrome (RPLS) in a Psoriasis Patient Treated With Ustekinumab.
    Dickson L; Menter A
    J Drugs Dermatol; 2017 Feb; 16(2):177-179. PubMed ID: 28300862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Three cases demonstrating the characteristic neuroimaging of reversible posterior leukoencephalopathy syndrome].
    Kusumoto K; Tajitsu K; Sakamoto A; Yokoyama S
    No Shinkei Geka; 2008 May; 36(5):423-8. PubMed ID: 18516860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible posterior leukoencephalopathy syndrome.
    Moon JM; Chun BJ
    J Emerg Med; 2010 Apr; 38(3):e1-4. PubMed ID: 18024064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of reversible posterior leukoencephalopathy syndrome(RPLS)induced by modified FOLFOX6].
    Matsunaga M; Miwa K; Araki K; Sunakawa Y; Yamashita K; Kaneta T; Nakayama H; Noguchi T; Nagashima F; Sasaki Y
    Gan To Kagaku Ryoho; 2012 Aug; 39(8):1283-6. PubMed ID: 22902460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible posterior leukoencephalopathy syndrome in a child treated with bevacizumab.
    Levy CF; Oo KZ; Fireman F; Pierre L; Bania MA; Sadanandan S; Yamashiro DJ; Glade Bender JL
    Pediatr Blood Cancer; 2009 May; 52(5):669-71. PubMed ID: 19101996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum and potential pathogenesis of reversible posterior leukoencephalopathy syndrome.
    Li Y; Gor D; Walicki D; Jenny D; Jones D; Barbour P; Castaldo J
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):873-82. PubMed ID: 21703874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features of preeclampsia-eclampsia patients with reversible posterior leukoencephalopathy syndrome].
    Lu HY; Xie BD; Cheng Y; Niu XM
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(3):178-81. PubMed ID: 20356553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical spectrum of reversible posterior leukoencephalopathy syndrome.
    Lee VH; Wijdicks EF; Manno EM; Rabinstein AA
    Arch Neurol; 2008 Feb; 65(2):205-10. PubMed ID: 18268188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed reversible posterior encephalopathy syndrome following chemotherapy with oxaliplatin.
    Sharief U; Perry DJ
    Clin Colorectal Cancer; 2009 Jul; 8(3):163-5. PubMed ID: 19632931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bifrontal headache · blurred vision · vomiting · Dx?
    Hughes WM; Villalon-Gomez JM
    J Fam Pract; 2015 Jun; 64(6):358-60. PubMed ID: 26172627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of cerebellar variant of posterior reversible encephalopathy syndrome in puerperium].
    Uchiyama T; Okamoto H; Koguchi M; Ogata A; Suzuyama K; Matsushima T
    No Shinkei Geka; 2013 Aug; 41(8):697-702. PubMed ID: 23907477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible posterior leukoencephalopathy in connective tissue diseases.
    Min L; Zwerling J; Ocava LC; Chen IH; Putterman C
    Semin Arthritis Rheum; 2006 Jun; 35(6):388-95. PubMed ID: 16765716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible posterior leukoencephalopathy syndrome: a case presentation.
    Bell AJ
    Neurodiagn J; 2012 Mar; 52(1):20-33. PubMed ID: 22558644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible posterior leucoencephalopathy syndrome associated with anticancer drugs.
    Marinella MA; Markert RJ
    Intern Med J; 2009 Dec; 39(12):826-34. PubMed ID: 19220526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reversible posterior leukoencephalopathy syndrome in a patient presenting granulomatosis with polyangiitis].
    Chaput L; Rabot N; Limousin N; Cottier JP; Lioger B; Samimi M
    Ann Dermatol Venereol; 2017 Feb; 144(2):113-120. PubMed ID: 27502754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible posterior leukoencephalopathy syndrome caused by blood transfusion: a case report.
    Huang YC; Tsai PL; Yeh JH; Chen WH
    Acta Neurol Taiwan; 2008 Dec; 17(4):258-62. PubMed ID: 19280871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reversible posterior leukoencephalopathy syndrome (RPLS) associated with Wegener's granulomatosis: a case report and review of the literature].
    Onozawa R; Tsuboi Y; Obata T; Inoue H; Yamada T; Miyake K
    Rinsho Shinkeigaku; 2012; 52(8):567-70. PubMed ID: 22975855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical case of reversible posterior leucoencephalopathy syndrome associated with puerperal HELLP syndrome.
    Peng WX; Nakaii M; Matsushima T; Asakura H
    Arch Gynecol Obstet; 2008 Sep; 278(3):269-71. PubMed ID: 18247035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors.
    Burnett MM; Hess CP; Roberts JP; Bass NM; Douglas VC; Josephson SA
    Clin Neurol Neurosurg; 2010 Dec; 112(10):886-91. PubMed ID: 20800343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.